Urine Drug Testing
LabCorp is an industry-leading provider of urine drug testing services. Our SAMHSA1-certified laboratories conduct urine drug analyses in accordance with DHHS2 and DOT3 requirements. Testing of non-regulated specimens is conducted using comparable stringent protocols.
Our strategically located laboratories offer a full range of testing services and provide prompt turnaround time nationwide. Uniform laboratory processes and a single computer platform provide standardized reporting regardless of testing location. Click on the Locations tab above for testing laboratory locations and contact information.
Standard urine drug testing panels range from 5 drugs to 10 drugs. Specimen validity testing is available to detect adulterants or specimen substitution resulting from a donor’s attempts to mask drug use. Expanded profiles for Medical Professional monitoring are also available.
Drugs of Abuse Reference Guide
The guide provides common drugs of abuse
that may be included in a urine drug-screening panel. Information contained in the Drugs of Abuse Reference Guide
is to be used as general guidelines only. LabCorp encourages the use of a Medical Review Officer (MRO) to review all
nonnegative results. Many variables may affect duration of detectability, such as drug metabolism and half-life,
subject's physical condition, fluid balance and state of hydration, and route and frequency of ingestion. The urine
drug detection guidelines and specimen validity data are provided by Dade Behring Inc, producer of Syva® products.
References
- Substance Abuse and Mental Health Services Administration
- Department of Health and Human Services
- Department of Transportation